Cognitive Training Using Feuerstein Instrumental Enrichment (Feuerstein)

September 22, 2019 updated by: Tzvi Dwolatzky, Rambam Health Care Campus

An Evaluation of the Feuerstein Instrumental Enrichment Program for the Cognitive Enhancement of Older People With Mild Cognitive Impairment (MCI) Living in the Community

Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above. The program is an applied practicable program based on the theories of Structural Cognitive Modifiability as well as on a Mediated Learning Experience. The program takes into consideration the unique characteristics and requirements of the older population. The program is composed of a variety of cognitive tasks that offer systematic activities intended to stimulate mental and cognitive development.

Objective: To examine the influence of the Feuerstein Program on the cognitive function and well-being of participants suffering from Mild Cognitive Impairment (MCI).

Hypothesis: The Feuerstein Program will improve cognitive abilities and functional well-being of the participants.

Methods: Residents of retirement homes will be offered to participate in the research. Participants will undergo cognitive and functional assessments that will be carried out on four specific dates. The participants of the Intervention Group will participate in the Feuerstein program using a method of mediated learning while the Control Group will participate in a program of the Adler Institute involving activities aimed at social and emotional development without specific cognitive skill training.

Study Overview

Detailed Description

Introduction

In recent decades, with the increase in life expectancy, the number of older people and their relative rate within the population have risen dramatically. This trend led to increased rates of people suffering from a mild cognitive disorder and dementia in developed countries. Mild Neurocognitive Disorder or Mild Cognitive Impairment (MCI) is defined as a transition state between successful aging and a state of dementia. This state is characterized by cognitive impairment and a decline in memory skills while daily functioning is maintained.

Older people diagnosed with MCI are at increased risk of developing dementia, particularly Alzheimer's disease. This risk is ranked at about 12% every year.

Since this is a pre-dementia stage, great importance lies in finding methods that could have prevented or at least decelerated the progress of MCI to dementia. Among the few effective programs are physical and cognitive activity.

The Feuerstein Program

This program is designated to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above (hereinafter "The Feuerstein Program"). The program is the initiative and brainchild of Professor Reuven Feuerstein - Israel Prize Laureate, founder and President of the Feuerstein Institute for the Enhancement of Learning Potential.

The program is an applied practicable program based on the theories of Structural Cognitive Modifiability as well as on Mediated Learning Experience. For the needs of this program, the tools were suited to the unique characteristics and requirements of the elderly population.

The program is composed of a variety of tools (hereinafter: instrumental enrichment) that offer systematic activities intended to stimulate mental and cognitive development.

Instrumental enrichment is a set of tools dealing with required thinking skills and it is designated to significantly promote learning and thinking processes. The tasks of the various tools are free of educational content and they engage in pure learning and thinking processes. The tools are delivered through special mediation processes, for which teachers and supervisors are trained in specialized courses.

Objectives of the Feuerstein Program

The main objective: to enhance the transformation (variability) capacity of a human being.

The sub-objectives:

  1. Correction and development of defective thinking skills, that are responsible for learning difficulties and the absence of transformation (variability).
  2. Equipping the learner with literal and conceptual content that he requires during his learning processes.
  3. Creating and establishing proper sound thinking and working habits.
  4. Creating insight and awareness regarding the processes involved in learning.
  5. Creating internal motivation for carrying out tasks.

The Learning Process

The instrumental enrichment tools are distributed to the participant as work sheets. The teacher creates a "mediating" dialogue between himself and the participants, thus enabling them to construct learning skills and essential thinking strategies. In addition, the teacher bridges the learning skills that were studied to the daily life of the elderly participant.

Products

  1. Creating within them awareness to their learning and thinking processes (Metacognition) while introducing an optimistic and positive attitude towards the ability to effect a significant change in these areas.
  2. Instill the elderly person with control over his thinking skills.
  3. Enhancing the sense of capability of the elderly person.

The Intervention Focuses of the Instrumental Enrichment Tools that will be utilized in the Program

  1. Methodical information gathering.
  2. Orientation and function in space and time.
  3. Comparison and sorting capabilities.
  4. Memory.
  5. Raising hypotheses and their examination.
  6. Perspicuousness (clear wording) and naming capabilities.

The Control Group

The Control Group will participate in a program of the Adler Institute involving activities aimed at social and emotional development without specific cognitive skill training.

Research Objective

To examine the influence of the Feuerstein Program on the cognitive condition of participants suffering from Mild Cognitive Impairment (MCI).

Research Hypothesis

The Feuerstein Program will improve the cognitive and functional condition of the participants.

Methodology

Randomised controlled intervention study involving subjects with Mild Neurocognitive Disorder.

Research Assessment Tools

  1. Cognitive screening by means of the MoCA (Montreal Cognitive Assessment) Test.
  2. Instrumental daily function assessed by the Lawton and Brody's Instrument.
  3. Depression screening based on the following question: "Are you feeling sad or depressed?". A positive response to this question has been found to be an efficient screening tool for depression.
  4. Will to live based on the following question: If you could describe your will to live on a scale between 0 and 5, would you say that it is: 5 = very strong and 0 = no will to live.
  5. CogSym (Cognitive Symptom) Meta-cognition questionnaire composed of ten items related to the cognitive ability of the examinee during his daily functioning. The examinee is asked to assess for each item, what is his ability level for the function being described, on a 5 levels scale (1 = excellent, 5 = inferior).
  6. World Health Organization well-being index questionnaire.
  7. The Neurotrax computerized cognitive assessment battery.

The intervention

Participants will be randomly allocated to an Intervention Group using the Feuerstein Program and a Control Group of the Adler Institute involving 30 twice weekly sessions each lasting 90 minutes over 15 weeks. Assessments will be performed at baseline, after session 15 and session 30, and finally at 6 months following study commencement.

Data Analysis The statistical analysis will be conducted as is customary in clinical research within the field.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beersheba, Israel
        • Beit Yona
      • Jerusalem, Israel, 91450
        • Ramat Tamir Retirement Home
      • Jerusalem, Israel, 9550100
        • Beit Tovei Hair
      • Qiryat Moẕqin, Israel, 2640143
        • Bayit Balev Beit Ildan
      • Tel Aviv, Israel
        • Bayit Balev Tel Aviv

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Aged 60 and above.
  2. Hebrew/English speakers.
  3. Expressing willingness to participate in the research and deliberately signing a consent form.
  4. A diagnosis of MCI exists according to accepted clinical criteria - the examinee's score in the MoCA Test is within the range of 18-26 (inclusive).

Exclusion Criteria:

  1. A medical or functional condition that will not allow the patient to participate in the intervention program within the research period.
  2. Diagnosed patients suffering from depression, bipolar disorder or schizophrenia.
  3. Patients who suffer from a diagnosed cognitive impairment other than MCI (delirium dementia or mental retardation).
  4. Visual impairment that hasn't been amended by glasses.
  5. Hearing impairment that hasn't been amended by a hearing aid.
  6. Examinees whose MoCA Test's score is 17 and below or 27 and above.
  7. Examinees who will receive the maximal score in one or more sections of the Lawton Test.
  8. Examinees who will respond positively to a filter question regarding the topic of depression.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Feuerstein Program
The participants of the Intervention Group will participate in the Feuerstein mediated learning cognitive program.
Mediated learning cognitive enhancement program
Placebo Comparator: Adler Program
The Control Group will participate in the program of the Adler Institute dealing with social and emotional development without specific cognitive skills training.
Social and emotional group program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline cognitive function
Time Frame: Through study completion, an average of 6 months
Based on Neurotrax computerized neuropsychological assessment battery
Through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2015

Primary Completion (Actual)

May 31, 2016

Study Completion (Actual)

May 31, 2016

Study Registration Dates

First Submitted

May 4, 2016

First Submitted That Met QC Criteria

May 12, 2016

First Posted (Estimate)

May 17, 2016

Study Record Updates

Last Update Posted (Actual)

September 24, 2019

Last Update Submitted That Met QC Criteria

September 22, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • RMC_TD_23/2015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on Feuerstein Program

Subscribe